Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

Watching HIV mature into an infection

BioPhotonics
Dec 2008
Amanda D. Francoeur, amanda.francoeur@laurin.com

HIV, the virus that causes AIDS, now can be seen maturing from its inactive form into an active infection. The process, which has never been seen before, could provide researchers with the information they need to develop advanced therapeutic treatments that would intervene with the disease’s progression and slow the infection.

Dr. Chun Tang, assistant professor of biochemistry in the school of medicine at the University of Missouri-Columbia, and fellow researchers at the National Institutes of Health in Bethesda, Md., used paramagnetic relaxation enhancement, a sensitive nuclear magnetic resonance method, to visualize the process. “It’s very sensitive to the minor species and small population,” Tang said.

BNhiv.jpg
Researchers now can use paramagnetic relaxation enhancement to watch an HIV-1 protease become an active infection. During the maturation process, two subunits of the same small chain (blue and green peptides) combine to create a precursor. Once the precursor is active, the tail (yellow strand) is cleaved, and the virus continues to infect other cells.


The researchers focused on an HIV-1 protease – the primary enzyme responsible for releasing the mature HIV-1 viral particles that cause AIDS. At first, the enzyme is inactive, and the virus is harmless to its host. “There must be two equivalent halves to form an active enzyme,” Tang said. During the maturation process, the protease becomes active and gains infectivity through introduction to another protease protein. The two proteins attach to each other to create a homodimer, a biological entity consisting of two equivalent subunits, through hydrogen bonding. Both subunits consist of 99 amino acids.

Once the halves merge, a tunnel develops between them. There are three main catalytic residues – aspartic, threonine and glycine amino acids – that form within the tunnel to make the dimer active. The “tail” of the precursor, a flanking amino acid residue, inserts itself into the tunnel and makes transient contact with both subunits. The tail is then cleaved by hydrolysis in two major locations for the protease to mature, thus allowing the virus to infect new cells.

An estimated 1.3 million people in North America were living with HIV infection in 2007, according to data compiled by the United Nations and the World Health Organization. The process of finding treatment is very difficult, as the viral enzyme constantly changes to gain drug resistance. However, according to Tang, visualizing the maturation process may allow researchers to enhance peptide treatments that could block the HIV-1 dimer and inhibit the protease from becoming active.

Nature, Oct. 2, 2008, pp. 693-698.


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!